Antiproliferative effects of an analog of curcumin in Hep-2 cells: A comparative study with curcumin

Natural Product Communications

Volumn 8, Issue 2, 2013, Pages 183-186

  Kumaravel, Mohankumar ^a   Sankar, Pajaniradje ^a   Latha, Periyasamy ^a   Benson, Chellakan S ^b   Rukkumani, Rajagopalan ^a  

^a PONDICHERRY UNIVERSITY   (India)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

Cancer; Curcumin; Curcumin analog; Cyclin D1; Flow Cytometry; Hep 2

Indexed keywords

BETA ACTIN; CURCUMA LONGA EXTRACT; CURCUMIN; CYCLIN D1; DEMETHOXYCURCUMIN; LACTATE DEHYDROGENASE; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ASSAY; CELL COUNT; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL VIABILITY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; CURCUMA LONGA; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG PURITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ASSAY; ENZYME RELEASE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INHIBITION KINETICS; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84875769267     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1300800213     Document Type: Article

References (28)

1. Murthy NS, Rajaram D, Gautham MS, Shivaraj NS, Nandakumar BS, Pruthvish S. (2011) Risk of cancer development in India. Asian Pacific Journal of Cancer Prevention, 12, 387-391.
2. Lee KM, Lee KW, Byun S, Jung SK, Seo SK, Heo YS, Bode AM, Lee HJ, Dong Z. (2010) 5- Deoxykaempferol plays a potential therapeutic role by targeting multiple signalling pathways in skin cancer. Cancer Prevention Research, 3, 454-465.
3. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. (2008) Curcumin and cancer: An old-age disease with an age-old solution. Cancer Letters, 267, 33-164.
4. Bansal SS, Goel M, Aqil F, Vadhanam MV, Gupta RC. (2011) Advanced drug-delivery systems of curcumin for cancer chemoprevention. Cancer Prevention Research, 4, 1158-1171.
5. Weng CJ, Yen GC. (2012) Chemopreventive effects of dietary phytochemicals against cancer invasion and metastasis: Phenolic acids, monophenol, polyphenol, and their derivatives. Cancer Treatment Reviews, 38, 76-87.
6. Badreldin HA, Husnia M, Salwa AN, Amel OB, Gerald B. (2006) Some biological properties of curcumin: a review. Natural Product Communications, 1, 509-521.
7. Keivan Z, Elissa R, Khosro M, Saeed T, Iman D, Zahra R, Moradali F, Forough Y, Fatemeh F. (2010) Evaluation of antiviral activities of curcumin derivatives against HSV-1 in vero cell line. Natural Product Communications, 5, 1935-1938.
8. Katsori AM, Chatzopoulou M, Dimas K, Kontogiorgis C, Patsilinakos A, Trangas T, Hadjipavlou-Litina D. (2011) Curcumin analogues as possible anti-proliferative and anti-inflammatory agents. European Journal of Medicinal Chemistry, 46, 2722-2735.
9. Anto RJ, Kuttan G, Dinesh Babu KV, Rajasekharan KN, Kuttan T. (1996) Antitumor and free radical scavenging activity of synthetic curcuminoids. International Journal of Pharmaceutics, 131, 1-7.
10. Chen CY, Yang WL, Kuo SY. (2011) Cytotoxic activity and cell cycle analysis of hexahydrocurcumin on SW 480 human colorectal cancer cells. Natural Product Communications, 6, 1671-1672.
11. Kim MK, Park JC, Chong Y. (2012) Aromatic hydroxyl group plays a critical role in antibacterial activity of the curcumin analogues. Natural Product Communications, 7, 57-58.
12. Dong HP, Yang RC, Chunag IC, Huang LJ, Li HT, Chen HL, Chen CY. (2012) Inhibitory effect of hexahydrocurcumin on human platelet aggregation. Natural Product Communications, 7, 883-884.
13. Lev-Ari S, Starr A, Vexler A, Karaush V, Loew V, Greif J, Fenig E, Aderka D, Ben-Yosef R. (2006) Inhibition of pancreatic and lung adenocarcinoma cell survival by curcumin is associated with increased apoptosis, down-regulation of COX-2 and EGFR and inhibition of Erk1/2 activity. Anticancer Research, 26, 4423-4430.
14. Mitra A, Chakrabarti J, Banerji A, Chatterjee A, Das BR. (2006) Curcumin, a potential inhibitor of MMP-2 in human laryngeal squamous carcinoma cells Hep-2. Journal of Environmental Pathology, Toxicology and Oncology, 25, 679-690.
15. Reddy S, Rishi AK, Xu H, Levi E, Sarkar FH, Majumdar AP. (2006) Mechanisms of curcumin and EGF-receptor related protein (ERRP) - dependent growth inhibition of colon cancer cells. Nutrition Cancer, 55, 185-194.
16. Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. (2006) Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Molecular Cancer Therapeutics, 106, 2503-2513.
17. Hauser PJ, Han Z, Sindhwani P, Hurst RE. (2007) Sensitivity of bladder cancer cells to curcumin and its derivatives depends on the extracellular matrix. Anticancer Research, 27, 737-740.
18. Tse AN, Carvajal R, Schwartz GK. (2007) Targeting checkpoint kinase 1 in cancer therapeutics. Clinical Cancer Research, 13, 1955-1960.
19. Mackenzie GG, Queisser N, Wolfson ML, Fraga CG, Adamo AM, Oteiza PI. (2008) Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells. International Journal of Cancer, 123, 56-65.
20. Sun M, Estrov Z, Ji Y, Coombes KR, Harris DH, Kurzrock R. (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Molecular Cancer Therapeutics, 7, 464-473.
21. Sun Li-qun, Chen Ou, Zhao Ming. (2006) Curcumin induces Hep-2 cell apoptosis and has effects on cell cycle phases. Chinese Journal of Laboratory Diagnosis, doi: CNKI:SUN:ZSZD.0.2006-01-016.
22. Sherr CJ. (1995) D-type cyclins. Trends in Biochemical Sciences, 20, 187-190.
23. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB. (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene, 21, 8852-8861.
24. Devasena T, Rajasekaran KN, Gunasekaran G, Viswanathan P, Menon VP. (2003) Anticarcinogenic effect of bis-1, 7-(2-hydroxyphenyl)-hepta-1,6- diene-3,5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacological Research, 47, 133-140.
25. Dinesh Babu KV, Rajasekharan KN. (1994) Simplified conditions for the synthesis of curcumin I and other curcuminoids. Organic Preparations and Procedures International, 24, 674-677.
26. Mossman T. (1983) Rapid colorimetric assay for cellular growth and survival: An application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55-63.
27. King J. (1965) Practical Clinical Enzymology, D. Van Nostrand Company Ltd., 83-93.
28. Fido RJ, Tatham AS, Shewry PR. (1995) Western blotting analysis. Methods in Molecular Biology: Plant gene transfer and expression protocols, Jones H. (Ed.). 49, 423-437.